Central African Republic vs Mus: Hepatitis B surface antigen (HBsAg) prevalence (%)
Central African Republic
5.3%
in 2024
Mus
0.8%
in 2024
Central African Republic rank
1st
Mus rank
1st
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Central African Republic
- Mus
How they compare
Central African Republic currently reports 5.3% against 0.8% in Mus, a difference of 4.5%.
That makes Central African Republic's figure about 6.6 times Mus's.
Across all 10 years both countries report, Central African Republic has been ahead every year.
Central African Republic ranks 1st and Mus ranks 1st of 194 countries.
Central African Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.0% | 1.2% | 8.8% | Central African Republic |
| 2020s | 7.0% | 0.8% | 6.1% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Central African Republic or Mus?
- Central African Republic, at 5.3% against 0.8% in Mus as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Central African Republic and Mus?
- 4.5%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Mus?
- 10 years are reported by both, from 2015 to 2024.
- How do Central African Republic and Mus rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Central African Republic ranks 1st and Mus ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.